- Home
- DRUG vs SPIR Comparison
DRUG vs SPIR Comparison
Compare DRUG & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- SPIR
- Stock Information
- Founded
- DRUG 2019
- SPIR 2012
- Country
- DRUG United States
- SPIR United States
- Employees
- DRUG N/A
- SPIR N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- SPIR Telecommunications Equipment
- Sector
- DRUG Health Care
- SPIR Consumer Discretionary
- Exchange
- DRUG Nasdaq
- SPIR Nasdaq
- Market Cap
- DRUG 364.8M
- SPIR 347.1M
- IPO Year
- DRUG N/A
- SPIR N/A
- Fundamental
- Price
- DRUG $56.97
- SPIR $7.52
- Analyst Decision
- DRUG Strong Buy
- SPIR Strong Buy
- Analyst Count
- DRUG 9
- SPIR 4
- Target Price
- DRUG $81.67
- SPIR $15.75
- AVG Volume (30 Days)
- DRUG 190.6K
- SPIR 524.8K
- Earning Date
- DRUG 12-30-2025
- SPIR 11-03-2025
- Dividend Yield
- DRUG N/A
- SPIR N/A
- EPS Growth
- DRUG N/A
- SPIR N/A
- EPS
- DRUG N/A
- SPIR 1.13
- Revenue
- DRUG N/A
- SPIR $93,285,000.00
- Revenue This Year
- DRUG N/A
- SPIR N/A
- Revenue Next Year
- DRUG N/A
- SPIR $5.97
- P/E Ratio
- DRUG N/A
- SPIR $6.63
- Revenue Growth
- DRUG N/A
- SPIR N/A
- 52 Week Low
- DRUG $23.18
- SPIR $6.85
- 52 Week High
- DRUG $70.23
- SPIR $21.43
- Technical
- Relative Strength Index (RSI)
- DRUG 49.89
- SPIR 28.55
- Support Level
- DRUG $55.01
- SPIR $8.40
- Resistance Level
- DRUG $61.81
- SPIR $9.22
- Average True Range (ATR)
- DRUG 3.80
- SPIR 0.64
- MACD
- DRUG -0.06
- SPIR -0.30
- Stochastic Oscillator
- DRUG 61.06
- SPIR 4.07
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About SPIR Spire Global Inc.
Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.